Dr. Syed Ali Husain, MD

Dr. Husain practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Husain's NPI, 1952696221, was assigned on June 15, 2011. Dr. Husain graduated from Rutgers New Jersey Medical School in 2011. Dr. Husain holds New York license 279935.

Dr. Husain's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Husain's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Husain is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Husain to 4 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Husain practices. Vendor and product names are available with a free account.

Nephrology is Dr. Husain's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Husain is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Husain's licenses on file in 3 states: New York, New Jersey and Massachusetts.

CMS data shows 303 Medicare services from Dr. Husain across 4 procedure codes in 2024, for 117 Medicare patients. Medicare paid $28,529 for them.

CMS counts 117 Medicare patients who saw Dr. Husain in 2024. The largest group is under 65, with 51 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 46% are also on Medicaid. Their average risk score is 5.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Husain's median patient age at 59, with 37% women.

In 2024, Dr. Husain wrote 304 Medicare Part D claims for 32 patients. 86% of them were for generic drugs. CMS names the drug for 133 of them, across 10 drugs with 11 or more claims each, at $3,338 in total drug cost. In 2023, CMS named 80 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Husain for performance year 2024, reported through an alternative payment model (APM). Dr. Husain accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Husain as offering telehealth.

Dmand AI links 121 papers to Dr. Husain, published from 2017 to 2025. 2021 was the busiest year, with 26. The most frequent topics are Kidney Transplantation, Kidney and Tissue Donors. Dr. Husain has published most often in Am J Transplant. Dr. Husain's most frequent co-authors are Sumit Mohan, MD, Lloyd E. Ratner, MD and Joel T. Adler, MD, MPH.

CMS Open Payments shows 22 general payments to Dr. Husain from 8 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 63% of the total. Novartis Pharmaceuticals Corporation paid the most, $7,583.

Dr. Husain graduated from Rutgers New Jersey Medical School in 2011.

Dr. Husain is in network with 19 carriers, including Excellus BlueCross BlueShield, United Healthcare and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.